MDM2 gene amplification [Test in Focus] - Insights
William Sukov, M.D., provides an overview of the MDM2 gene amplification assay — a test that looks for amplification of the MDM2 gene region on chromosome 12q. He reviews when this test should be ordered, how it compares to other test...
Plasma Cell Proliferative Disorder [Test in Focus] - Insights
Linda Baughn Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be...
B-cell lymphoblastic leukemia monitoring for minimal residual disease [Test in Focus] - Insights
Min Shi, M.D., Ph.D., a hematologist and co-director of Mayo Clinic's Flow Cytometry Laboratory, explains recent updates to the B-cell lymphoblastic leukemia minimal residual disease flow cytometry assay. This test is used to identify...
Myelodysplastic syndrome - Insights
Browse our wide variety of testing options for the prognosis and risk stratification associated with myelodysplastic syndrome.
See how our Special Coagulation Laboratory offers algorithmic approaches to meet your bleeding disorder testing needs.
Monthly updates to current procedural terminology (CPT) codes and logical observation identifiers names and codes (LOINC).
Sarcoma NGS Testing - Mayo Clinic Laboratories
n order to aid in the diagnosis for a wide range of tumors, our sarcoma NGS panel includes fusions in 138 individual genes.
Comprehensive panels - Insights
Learn how our in-depth genetic testing can determine whether a cancer is hereditary in origin for individuals with a family history of cancer.
Find out how patients with a cancer diagnosis can benefit from single-gene analysis to pinpoint whether the cancer is genetic in nature.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.